2020-06-24
Positive results from Phase 2 study
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2020-06-24
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2019-08-26
Australia has announced that Camurus’ treatment Buvidal® (buprenorphine) will be listed through the Pharmaceutical B…
Read more2019-08-07
ISEC has launched three new products for better and safer surveillance of radioactive environments.
Read more2019-07-23
Camurus’ partner Braeburn have received a positive outcome in the US court proceedings which were initiated in April…
Read more2019-06-20
The FDA has approved Camurus’ Investigational New Drug application to initiate a Phase 3 study with CAM2029 once-mon…
Read more2019-06-17
Starting June 2019, all Sandberg Development's office and production facilities will be cleaned and washed with DIRO…
Read more